首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study.
【24h】

Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study.

机译:水解蛋白婴儿配方食品对生长的长期影响-延长随访至10岁:德国婴儿营养干预(GINI)研究的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Previous analysis in a prospective, population-based cohort reported reduced weight gain in children fed extensively hydrolyzed casein (eHF-C) formula during the first year of life but showed no effect on growth between 1 and 6 y of life. No studies have been conducted in children up to the age of 10 y. OBJECTIVE: The objective was to investigate potential differences in body mass index (BMI) over the first 10 y of life between infants fed within the intervention period of the first 16 wk of life with partially hydrolyzed whey (pHF-W), extensively hydrolyzed whey (eHF-W), eHF-C, or cow-milk formula (CMF) and infants exclusively breastfed (BF) within the intervention period. DESIGN: This was a prospective, randomized, double-blind trial in full-term neonates with atopic heredity in the German birth cohort German Infant Nutritional Intervention (GINI) followed through the first 10 y of life. Analyses of absolute and World Health Organization (WHO)-standardized BMI trajectories for 1840 infants [pHF-W (n = 253), eHF-W (n = 265), eHF-C (n = 250), CMF (n = 276), and BF (n = 796)] were conducted according to intention-to-treat principles. RESULTS: Except for the previously reported slower BMI gain in infants fed with eHF-C formula within the first year of life, no significant differences in absolute or WHO-standardized BMI trajectories were shown between the pHF-W, eHF-W, eHF-C, CMF, and BF groups thereafter up to the age of 10 y. CONCLUSIONS: Extension of the follow-up period from 6 to 10 y for this randomized controlled trial showed no long-term consequences on BMI for the 4 infant formulas considered. These data need to be confirmed in future studies.
机译:背景:先前在一项基于人群的前瞻性分析中,报道了在生命的第一年中,广泛摄入酪蛋白水解物(eHF-C)配方食品的儿童体重增加减少,但未对1至6年的生长产生影响。尚未对10岁以下的儿童进行任何研究。目的:研究在生命的前16周内,部分水解乳清(pHF-W),广泛水解的乳清在干预后喂养的婴儿在出生后10年内的体重指数(BMI)的潜在差异(eHF-W),eHF-C或牛奶配方(CMF),以及在干预期内仅母乳喂养的婴儿(BF)。设计:这是一项前瞻性,随机,双盲试验,针对德国出生队列德国婴儿营养干预(GINI)中特应性遗传的足月新生儿,随访至生命的最初10年。对1840名婴儿的绝对和世界卫生组织(WHO)标准化BMI轨迹进行分析[pHF-W(n = 253),eHF-W(n = 265),eHF-C(n = 250),CMF(n = 276) )和BF(n = 796)]是按照意向治疗原则进行的。结果:除先前报道的在出生后第一年内用eHF-C配方奶粉喂养的婴儿的BMI增幅减慢外,pHF-W,eHF-W,eHF-之间的绝对或WHO标准化BMI轨迹没有显着差异。 C,CMF和BF组此后直至10岁。结论:该随机对照试验将随访期从6年延长至10年,表明所考虑的4种婴儿配方食品对BMI均无长期影响。这些数据需要在未来的研究中得到证实。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号